A new preprint study shatters the idea that pediatric long COVID is just a mild or different version of the adult form.
It shows that children share the same core immune patterns - and, strikingly, some resemble those seen in chronic infections like HIV.🧵
The paper message is clear - pediatric LC is biologically defined immune dysfunction.
Children display
shifts in monocytes (↑ non-classical, ↓ CCR6),
T cell changes (↑ Tregs, ↓ central memory CD4, exhausted CD8),
exhausted B cells.
At the root lies a failure of antigen-presenting cells (monocytes & dendritic cells).
Normally, they carry viral information to T and B cells. But in LC, they express less CCR6/CCR7 - they can’t migrate properly to lymph nodes or activate adaptive immunity.
“Suppressed expression of CCR6 and CCR7… could impair antigen presentation and adaptive immunity.”
The consequence?
B cells don’t mount a strong antibody response.
Children with LC had significantly lower anti-RBD IgG and IgA titers, and their antibodies neutralized the virus less effectively.
The virus can persist in tissues, like the gut.
Meanwhile, T and NK cells become hyperactivated.
On the surface this looks like a strong immune defense. But in reality, it’s a dead end.
These cells show exhaustion markers (PD1, CD57, CD38, HLA-DR↑).
“Elevated expression of activation and exhaustion markers…”
A vicious cycle?
Persistence - activation - exhaustion - persistence again.
And here’s the striking part - the authors explicitly point to parallels with HIV.
“Elevated CXCR3 expression on CD8 TCM has also been reported in people living with HIV-1, suggesting a shared trait of chronic viral infections.”
The same is true for B cells.
Cluster 15 B cells show an exhausted-like phenotype -
“…commonly observed in chronic viral infections such as HIV-1.”
SARS-CoV-2 can imprint the immune system in children in ways that mimic chronic viral disease.
In pediatric LC, CD8 stem-cell like memory T cells (TSCM) decreased, while central memory T cells (TCM) increased.
And within TCM, there was a shift toward CXCR3+/CCR6+ cells - a phenotype of chronic stimulation.
The clinical point is sobering.
Weak antibodies + exhausted T/NK cells = a recipe for viral persistence.
When APCs don’t work (CCR6/CCR7↓), B cells never make high-quality antibodies.
The virus hides, the immune system pushes harder, and burns itself out.
The result?
A state of chronic immune imbalance.
Maybe less dramatic than HIV, but uncannily similar.
Pediatric LC emerges as a model of chronic viral immunopathology - not a psychological aftermath, but a biological condition with measurable immune signatures.
And perhaps we won’t need to argue about these parallels for long.
The authors themselves are already drawing them - between pediatric LC, adults with LC, and chronic infections like HIV.
Pujol et al., 2025. Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation. biorxiv.org/content/10.110…
Dobře si to přečtěte @szupraha @ZdravkoOnline @msmtcr @Hygiena_cz. LC je dnes nejčastější chronické onemocnění u dětí - překonává astma.
Tohle jsou následky vaší nečinnosti.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Long COVID may not begin only after the acute infection has passed. In at least some patients, the immune system appears to go off track from the very start. A breakthrough study.🧵
What makes this study especially interesting is that it does not just describe what patients with long COVID look like later on. Instead, it looks for differences already during acute hospitalization and then again three months later. That is its main strength - it tries to capture whether a risk immune signature is already present early.
The authors used mass cytometry with 40 markers and compared 10 patients who later developed long COVID with 13 similarly ill patients who did not.
Although this survey based study suggests some improvement over time, the burden of long COVID remains high, with millions of adults still affected and true biological recovery remaining uncertain🧵
This study analyzed data from the US National Health Interview Survey from 2022 to 2024 to examine how common long COVID is and how often people report recovering from it.
The main findings.
From 2022 to 2024, the share of US adults who reported ever having had COVID increased from 39.6% to 60.4%. Among those individuals, however, the proportion who reported ever having long COVID fell from 19.7% to 13.7%.
After SARS-CoV-2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19.
A study based on nationwide Swedish registries followed nearly 10 million people🧵
10 mio people aged 3-100 years from January 1, 2020, to November 30, 2022.
The authors divided participants into those without a COVID-19 diagnosis, those with a positive PCR test without hospitalization, and those hospitalized with COVID-19.
Main finding?
After SARS2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19. Among individuals with a positive PCR test who were not hospitalized, the adjusted relative risk was about 1.6 times higher, and among those hospitalized with COVID-19 it was about 5.7 times higher.
For many people, COVID did not end when the infection cleared - it evolved into a longer and far more complicated story.
This paper presents Long COVID as a heterogeneous, multisystem condition that can affect nearly every organ system🧵
This paper is a broad, wide ranging review of Long Covid. @elisaperego78 describes Long COVID as a heterogeneous, multisystem disease that can affect almost the entire body, with effects ranging from subtle or barely noticeable changes to severe disability or even death.
A key point throughout the paper is that this is not just fatigue after a viral illness, but a condition associated with measurable biological abnormalities.
In this cohort of healthcare workers infected with the original SARS2 variant, symptoms were still present even after a median of 47.5 months (!).
Brain fog may persist.
This is a prospective multicenter cohort study from Switzerland🧵
The study was designed in a fairly sensible way. The authors did not automatically treat every complaint as long COVID, but instead compared 24 chronic symptoms between the previously infected group and an uninfected control.
In this way, they identified 13 symptoms that occurred more frequently after prior infection. The most common were fatigue, smell/taste disturbance, so-called brain fog, meaning problems with concentration and cognition.
An interesting and biologically plausible pilot study that provides a fairly strong signal that pediatric Long COVID may be associated with impaired microcirculation and increased arterial stiffness🧵
The study builds on earlier adult research suggesting that persistent symptoms after COVID may be linked to capillary loss and endothelial dysfunction.
This was an observational comparative cohort study, not a randomized or interventional trial.
The study included 37 pediatric patients with Long COVID and 46 healthy controls. On average, the patients were evaluated about 206 ± 167 days after a positive test, so often many months after the initial infection.